Patent · US Active

Machine and procedure for extracorporeal treatment of blood

US8105260B2 · kind B2 · utility

79Cited by
2References
56Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 27, 2005
Grant dateJan 31, 2012
Priority date
Expiry dateMay 7, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/60
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A machine (1) for extracorporeal blood treatment comprises a device (2) for ultrafiltration of a liquid through a semi-permeable membrane (3) of a blood treatment device (4), a first sensor (11) for ultrafiltration rate through the membrane, a second group of sensors (13) for measuring a trans-membrane pressure, and a programmed controller (14) for calculating a maximum ultrafiltration rate as a function of the transmembrane pressure. The machine is suitable for kidney failure treatments, such as hemofiltration and hemodiafiltration. In a relatively short time the machine enables a large quantity of corporeal blood to be removed from the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.